[
    [
        {
            "time": "2018-03-16",
            "original_text": "【中信建投证券】每日精华推荐（2018.03.16）【医药】理顺管理机制，医改继续前行",
            "features": {
                "keywords": [
                    "中信建投证券",
                    "精华推荐",
                    "医药",
                    "管理机制",
                    "医改"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【中信建投证券】每日精华推荐（2018.03.16）【医药】理顺管理机制，医改继续前行",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        }
    ]
]